Wietske Kieboom has a diverse background in molecular and medical biology, with significant experience in research and analysis. At the Radboud Institute for Molecular Life Sciences from February to August 2023, Wietske contributed to the development of a triple-negative breast cancer cell line with specific genetic modifications and conducted research on the response of iPSC-derived keratinocytes to stimuli related to atopic dermatitis. Previous roles included pharmacogenetic analysis at Result Laboratorium, where Wietske validated NGS pharmacogenetic panels for diagnostic use, and research technician work at Radboudumc, focusing on the effects of prednisone on podocytes and generating retinal cells from patient-derived stem cells. Wietske holds a Bachelor of Science in Biology and Medical Laboratory Research from Avans University of Applied Sciences and is currently pursuing a Master of Science in Medical Biology at Radboud University, expected to graduate in 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices